These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2349428)

  • 21. Value of the peak expiratory flow in bronchodynamic tests.
    Pino JM; García-Río F; Prados C; Alvarez-Sala R; Díaz S; Villasante C; Villamor J
    Allergol Immunopathol (Madr); 1996; 24(2):54-7. PubMed ID: 8933890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary function in symptom-free asthmatics.
    Yaacob I; Mohammad M
    Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to bronchodilator in the asthmatic: an alternative method of analysis.
    Sobol BJ
    Ann Allergy; 1985 Aug; 55(2):114-5. PubMed ID: 4025955
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversibility of forced expiratory volume in 1 second (FEV1) by albuterol.
    Pisarik P
    Fam Med; 2006; 38(7):463-4. PubMed ID: 16823665
    [No Abstract]   [Full Text] [Related]  

  • 26. [When are bronchodilator agents sufficient in asthma/chronic obstructive pulmonary disease?].
    van Schayck CP; van Herwaarden CL; Folgering H; Akkermans R; van Weel C
    Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1580-3. PubMed ID: 7675140
    [No Abstract]   [Full Text] [Related]  

  • 27. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.
    Koskela HO; Kiviniemi V; Purokivi MK; Taivainen AH; Tukiainen HO
    Respir Med; 2006 Oct; 100(10):1760-6. PubMed ID: 16563715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative value of tests used to measure bronchodilator response.
    George RB; Conrad SA; Light RW
    Chest; 1978 Jun; 73(6 Suppl):989-90. PubMed ID: 354890
    [No Abstract]   [Full Text] [Related]  

  • 31. Is forced expiratory volume in one second the best measure of severity in childhood asthma?
    Spahn JD; Cherniack R; Paull K; Gelfand EW
    Am J Respir Crit Care Med; 2004 Apr; 169(7):784-6. PubMed ID: 14754761
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of spontaneous FEV1 fluctuation on airway reversibility estimation.
    Güçlü G; Sayiner A
    Monaldi Arch Chest Dis; 1994 Dec; 49(6):466-9. PubMed ID: 7711694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of bronchodilatation.
    Block AJ
    Chest; 1980 Sep; 78(3):496. PubMed ID: 7418472
    [No Abstract]   [Full Text] [Related]  

  • 34. Interpretation of bronchodilator response and the prescription of bronchodilators: the equivalent of tossing coins?
    Eliasson O
    J Asthma; 1985; 22(2):81-5. PubMed ID: 4019397
    [No Abstract]   [Full Text] [Related]  

  • 35. Should the FVC be considered in evaluating response to bronchodilator?
    Girard WM; Light RW
    Chest; 1983 Jul; 84(1):87-9. PubMed ID: 6861550
    [No Abstract]   [Full Text] [Related]  

  • 36. Criteria for bronchodilator response.
    de la Hoz RE
    Chest; 2002 Dec; 122(6):2263; author reply 2263-4. PubMed ID: 12475877
    [No Abstract]   [Full Text] [Related]  

  • 37. Absence of pharmacokinetic interaction between ambroxol and clenbuterol.
    Flores-Murrieta FJ; Castañeda-Hernández G; Hoyo-Vadillo C; Ocaña H; Pérez-Neria J; Hong E
    Proc West Pharmacol Soc; 1991; 34():329-33. PubMed ID: 1788306
    [No Abstract]   [Full Text] [Related]  

  • 38. It is high time we standardize the interpretation of bronchodilator responsiveness in children.
    Ben Saad H
    Pediatr Pulmonol; 2021 May; 56(5):1264-1265. PubMed ID: 33497506
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostic and therapeutic use of thiazinamium (Multergan)].
    van Bork LE; Jonkman JH; de Zeeuw RA; Orie NG; Peset R; de Vries K
    Ned Tijdschr Geneeskd; 1977 Jul; 121(30):1196-202. PubMed ID: 887179
    [No Abstract]   [Full Text] [Related]  

  • 40. What Is a Significant Bronchodilator Response?
    Kaminsky DA
    Ann Am Thorac Soc; 2019 Dec; 16(12):1495-1497. PubMed ID: 31774318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.